StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70−0.00 (-0.00%)

Close on Nov 18, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Curanex Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$4.25M. For fiscal 2025 it was -$10.48M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.48M–
FY2024Dec 31, 2024-$555.58K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.36M–
Q2 FY2026Jun 30, 2026-$1.08M–
Q1 FY2026Mar 31, 2026-$954.56K–
Q4 FY2025Dec 31, 2025-$857.40K–
Q3 FY2025Sep 30, 2025-$9.19M–
Q2 FY2025Jun 30, 2025-$290.08K–
Q1 FY2025Mar 31, 2025-$149.95K–
Q4 FY2024Dec 31, 2024-$95.43K–
Q3 FY2024Sep 30, 2024-$129.94K–

More Curanex Pharmaceuticals figures

See a number that looks wrong?